~~<i id='86351148FF'><strike id='86351148FF'><tt id='86351148FF'><pre id='86351148FF'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

leisure time

author：hotspot 2025-09-27 12:35:17 - browse：79311

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
Next article： Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

leisure time

hotspot

focus

knowledge

explore

focus

1:37FacebookCEOMarkZuckerbergspeaksabout"NewsTab"atthePaleyCenter,Oct.25,2019,inNewYork.MarkLennihan

WSS

Option Care buys Amedisys in $3.6 billion home care deal

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

An Ebola outbreak presents a new mystery involving children

CDC launches VaccineFinder tool to locate Covid

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Biden praises World Series champion Astros for impact off the field during White House celebration

hotspot

leisure time

leisure time

Jerome Adams on the need for new antivirals for Covid

PhRMA sues HHS over Medicare drug price negotiation

Medical records are filled with copy

Lessons Learned: This is why you network to find that industry job you want

23andMe had bad news about my health. I wish a person had delivered it

Inside the fall of star MIT scientist David Sabatini

Virginia high school admissions case could be legal follow

Ohioans vote in high

Cancer drug shortages should be causing more outrage

'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

hotspot

Listen: Biogen's messy board & Laronde's data problem

Former Georgia lieutenant governor says he received grand jury subpoena

Listen: Biogen's messy board & Laronde's data problem

FTX founder Sam Bankman

Biden praises World Series champion Astros for impact off the field during White House celebration

Van's Gluten Free Original Waffles recalled for possible wheat allergen

focus

knowledge

explore

focus